To investigate the relationship between SCARNA12 and its host gene PHB2, we examined clinical samples from CRC patients and found that SCARNA12 and PHB2 were highly expressed in 88% and 57% of CRC tissues, respectively. This evidence concerns the gene PHB2 and colorectal carcinoma.